1. Home > Latest Topics >

Question 12: Pharmacokinetic/pharmacodynamic variables for respiratory fluoroquinolones against Streptococcus pneumoniae

20 June, 2018

question_12_9


LATEST TOPICS

Managing Infectious Diseases in Emergency Medicine: A Specialist’s Approach
10 April, 2024
Advancing standardised diagnosis and treatment of acute infectious disease: Insights from an expert in theory–technique integration
08 April, 2024
Managing severe infections: Practical approaches for antibiotic use, including combination therapy
05 March, 2024
Updating Traditional Approaches: Expert Insights on Addressing Urinary Tract Infections
26 February, 2024
Antibiotic resistance may be driven by diverse factors, including extreme climatic events
14 February, 2024

RELATED ARTICLES

Antibiotic resistance may be driven by diverse factors, including extreme climatic events
14 February, 2024
Antimicrobial resistance in respiratory tract infections: Current trends and strategies
06 August, 2021
Observing the Development of Quinolones from the Rational Application of Antibacterial Drugs During the COVID-19 Pandemic
21 March, 2023
Community-acquired pneumonia: Insights into macrolide resistance and a review of levofloxacin use
05 July, 2021
Recent trends in the treatment of community-acquired pneumonia: A Japanese perspective
12 November, 2021